Personalized pregnancy care
Israel’s NUVO has partnered with Jerusalem’s Hadassah hospital to develop an AI platform for accurate decision-making about pregnancy complications. NUVO has also just received US FDA approval for its INVU device (reported here previously) to be used in monitoring maternal fetal heart rate.
This entry was posted in Israel's Medical Achievements
. Bookmark the permalink